臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"lu sn"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-25 of 29 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
國家衛生研究院	2025-08-06	Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019	Kee, KM;Chen, CH;Liu, TW;Huang, YH;Hu, JT;Chau, GY;Chen, KH;Chiang, CJ;Lin, CC;Hung, CF;Wang, TE;Huang, SF;Ku, HY;Huang, BS;Ch'ang, HJ;Tseng, HP;Lu, SN
國家衛生研究院	2022-12-31	Secular trends of clinical characteristics and survival of hepatocellular carcinoma in Taiwan from 2011 to 2019	Kee, KM;Chen, CH;Hu, JT;Huang, YH;Wang, TE;Chau, GY;Chen, KH;Chen, YL;Lin, CC;Hung, CF;Huang, SF;Liu, TW;Ku, HY;Huang, BS;Wang, YP;Tseng, HP;Chiang, CJ;Lu, SN
國家衛生研究院	2022-01-14	Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B	Hu, HH;Jeng, WJ;Pan, MH;Luo, WS;Chang, CL;Huang, YT;Su, CY;Chiang, CT;Jen, CL;Chien, YC;Lu, SN;Wang, LY;Huang, LR;Lee, MH;Liu, J;Nguyen, MH;Chen, CJ;Yang, HI
國家衛生研究院	2021-07-15	How may ramucirumab help improve treatment outcome for patients with gastrointestinal cancers?	Chen, MH;Lu, SN;Chen, CH;Lin, PC;Jiang, JK;D'Yachkova, Y;Lukanowski, M;Cheng, R;Chen, LT
國家衛生研究院	2020-03	Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO	Chen, LT;Martinelli, E;Cheng, AL;Pentheroudakis, G;Qin, S;Bhattacharyya, GS;Ikeda, M;Lim, HY;Ho, GF;Choo, SP;Ren, Z;Malhotra, H;Ueno, M;Ryoo, BY;Kiang, TC;Tai, D;Vogel, A;Cervantes, A;Lu, SN;Yen, CJ;Huang, YH;Chen, SC;Hsu, C;Shen, YC;Tabernero, J;Yen, Y;Hsu, CH;Yoshino, T;Douillard, JY
國家衛生研究院	2018-04-05	ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma	Abou-Alfa, G;Qin, S;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, G;Harris, WP;Chen, Z;Hubner, RA;Meyer, T;Sun, W;Harding, JJ;Hollywood, EM;Ma, J;Wan, PJ;Ly, M;Bomalaski, J;Johnston, A;Lin, CC;Chao, Y;Chen, LT
國家衛生研究院	2017-10	Serum soluble programmed cell death 1 level as a key predictor for spontaneous functional cure of chronic hepatitis B patients	Hu, HH;Pan, MH;Luo, WS;Chang, CL;Jeng, RWJ;Huang, YT;Su, CY;Chiang, CT;Jen, CL;Lu, SN;Wang, LY;Huang, LR;Shih, CH;Chen, CJ;Yang, HI
國家衛生研究院	2016-05	Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)	Abou-Alfa, GK;Qin, SK;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, GM;Harris, WP;Chen, ZD;Hubner, R;Meyer, T;Bomalaski, JS;Lin, CC;Chao, Y;Chen, LT
中國醫藥大學	2014-03	A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapse	(Lee CM);(Chen CY);(Chien RN);(Tseng KC);彭成元(Cheng-Yuan Peng);(Tung SY);(Fang YJ);(Huang YH);(Lu SN);(Hung CH);(Tsai TJ);(Fang CC);(Hsu CW);(Yeh CT)*
中國醫藥大學	2013-03	Prediction models of long-term cirrhosis and HCC risk in chronic hepatitis B patients: Risk scores integrating host and virus profiles	(Lee MH);楊懷壹(Hwai-I Yang);(Liu J);(Batrla-Utermann R);(Jen CL);(Iloeje UH);(Lu SN);(You SL);(Wang LY);(Chen CJ)*
中國醫藥大學	2012-12	A Predictive Scoring System for the Seroclearance of HBsAg in HBeAg-seronegative Chronic Hepatitis B Patients with Genotype B or C Infection	(Liu J);(Lee MH);(Batrla-Utermann R);(Jen CL);(Iloeje UH);(Lu SN);(Wang LY);(You SL);(Hsiao CK);楊懷壹(Hwai-I Yang);(Chen CJ)*
中國醫藥大學	2012-08	Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study	(Lee MH);楊懷壹(Hwai-I Yang);(Lu SN);(Jen CL);(You SL);(Wang LY);(Wang CH);(Chen WJ);(Chen CJ)*
中國醫藥大學	2012-04	Association between obesity, hypertriglyceridemia and low hepatitis B viral load	(Chiang CH);楊懷壹(Hwai-I Yang);(Jen CL);(Lu SN);(Wang LY);(You SL);(Su J);(Iloeje UH);(Chen CJ)*
臺北醫學大學	2012	A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy	Chang, KC;Hung, CH;Lu, SN;Wang, JH;LEE, CM;Chen, CH;Yen, MF;Lin, SC;Yen, YH;Tsai, MC;Tseng, PL;Hu, TH
中國醫藥大學	2011-11-08	Single nucleotide polymorphisms associatiedwith elevated serum viral load of hepatitis B virus in patients with chronic hepatitis B: A genome-wide assoiation study in Taiwan	(Lee MH);楊懷壹(Hwai-I Yang);(Lin YJ);(Jen CL);(Lu SN);(Yuan Y)(Litalian ;G);(Chen CJ)
中國醫藥大學	2011-09	Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C	(Huang YT);(Jen CL);楊懷壹(Hwai-I Yang);(Lee MH);(Su J);(Lu SN);(Iloeje UH);(Chen CJ)*
中國醫藥大學	2011-06	Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma	(Chen CF);(Lee WC);楊懷壹(Hwai-I Yang);(Chang HC);(Jen CL);(Iloeje UH);(Su J);(Hsiao CK);(Wang LY);(You SL);(Lu SN);(Chen CJ)*
國家衛生研究院	2010-09	A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients	Yang, TS;Lu, SN;Chao, Y;Sheen, IS;Lin, CC;Wang, TE;Chen, SC;Wang, JH;Liao, LY;Thomson, JA;Wang-Peng, J;Chen, PJ;Chen, LT
高雄醫學大學	2010	流行地區的B、C型肝炎與慢行腎臟病相關性--一個橫斷性研究	李佳蓉;林明彥;楊奕馨;盧勝男;陳鴻鈞;黃尚志; Lee JJ;Lin MY;Yang YH;Lu SN;Chen HC;Hwang SJ
國立臺灣大學	2008-12	Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.	Yang, WI; Yeh; SH, Chen, PJ; Iloeje, UH; Jen, CL; Su, J; Wang, LY; Lu, SN; You, SL; Chen, DS; Liaw, YF; Chen, CJ
國立臺灣大學	2008-11	Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan	Chen, CL; Yang, HI; Yang, WS; Liu, CJ; Chen, PJ; You, SL; Wang, LY; Sun, CA; Lu, SN; Chen, DS; Chen, CJ
國立臺灣大學	2008-08	Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.	Yang, HI; Yeh, SH; Chen, PJ; Iloeje, UH; Jen, CL; Su, J; Wang, LY; Lu, SN; You, SL; Chen, DS; Liaw, YF; Chen, CJ
國立臺灣大學	2008-07	Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.	Chen, CL; Yang, HI; Yang, WS; Liu, CJ; Chen, PJ; You, SL; Wang, LY; Sun, CA; Lu, SN; Chen, DS; Chen, CJ.
國立臺灣大學	2006-07	Village distribution and geographic variations of the prevalence of chronic hepatitis B, C and hypertransaminemia: an analysis of adult health examinations in 520 village of Tainan county, Taiwan	Chen, PF; Kee, KM; Chen, YD; Tsai, LS; Shih, LY; Lin, LC; Chen, THH; Lu, SN
高雄醫學大學	2006	A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide; multicentre study in Taiwan.	余明隆;林錫明;莊萬龍;戴嘉言;王景弘;盧勝男;沈一嫻;張文宇;李全謀;廖運範 ; Yu ML;Lin SM;Chuang WL;Dai CY;Wang JH;Lu SN;Sheen IS;Chang WY;Lee CM;Liaw YF

Showing items 1-25 of 29 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 51828783 ???header.onlineuser??? : 789 ???header.sponsordeclaration???